The Potential of MicroRNAs as Prostate Cancer Biomarkers

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy,
The PSA Era is not Over for Prostate Cancer
Methods of Rotation From Another Strong Opioid to Methadone for the Management of Cancer Pain: A Systematic Review of the Available Evidence  Sarah McLean,
Volume 60, Issue 2, Pages (August 2011)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Testosterone Therapy in Men With Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 71, Issue 2, Pages (February 2017)
Volume 70, Issue 1, Pages (July 2016)
Volume 70, Issue 1, Pages (July 2016)
Volume 67, Issue 4, Pages (April 2015)
Volume 63, Issue 1, Pages (January 2013)
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 4, Pages (October 2013)
Volume 66, Issue 3, Pages (September 2014)
Volume 69, Issue 1, Pages (January 2016)
Let the Games Begin (with EAU Approval)
Prostate Cancer Epidemic in Sight?
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration- resistant Prostate Cancer in the Era of Precision Oncology  Philipp.
Volume 65, Issue 6, Pages (June 2014)
Volume 64, Issue 4, Pages (October 2013)
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Volume 64, Issue 4, Pages (October 2013)
Methods of Rotation From Another Strong Opioid to Methadone for the Management of Cancer Pain: A Systematic Review of the Available Evidence  Sarah McLean,
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 4, Pages (October 2015)
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 54, Issue 4, Pages (October 2008)
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
Volume 63, Issue 6, Pages (June 2013)
Volume 70, Issue 3, Pages (September 2016)
Prostate Cancer Detection: A View of the Future
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Obesity and Prostate Cancer: A Role for Adipokines
Counselling the Prostate Cancer Patient
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Yuanshan Cui, Yong Zhang  European Urology 
Volume 72, Issue 5, Pages (November 2017)
Volume 71, Issue 4, Pages (April 2017)
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 71, Issue 1, Pages (January 2017)
Leonard S. Marks, Jiaoti Huang  European Urology 
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 68, Issue 6, Pages (December 2015)
Volume 73, Issue 2, Pages (February 2018)
Volume 62, Issue 6, Pages (December 2012)
Volume 72, Issue 2, Pages (August 2017)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Volume 74, Issue 6, Pages (December 2018)
Testicular Cancer Variations in Time and Space in Europe
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer  Amar U. Kishan, Rahul.
European Urology is “Your” Journal
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Systematic Review of Complications of Prostate Biopsy
Volume 54, Issue 3, Pages (September 2008)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

The Potential of MicroRNAs as Prostate Cancer Biomarkers Linda Fabris, Yvonne Ceder, Arul M. Chinnaiyan, Guido W. Jenster, Karina D. Sorensen, Scott Tomlins, Tapio Visakorpi, George A. Calin  European Urology  Volume 70, Issue 2, Pages 312-322 (August 2016) DOI: 10.1016/j.eururo.2015.12.054 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 Flow diagram for Preferred Reporting Items for Systematic Reviews and Meta-analysis showing the literature selection process resulting in the studies included in the review. European Urology 2016 70, 312-322DOI: (10.1016/j.eururo.2015.12.054) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 2 Schematic representation depicting the potential source of microRNAs in prostate cancer and their role as prognostic or diagnostic tools or as markers for therapy response. miRNA=microRNA. European Urology 2016 70, 312-322DOI: (10.1016/j.eururo.2015.12.054) Copyright © 2016 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.